Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double‐blind Controlled Trial.

MLA

Beltaief, Kaouthar, et al. “Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double‐blind Controlled Trial.” Academic Emergency Medicine, vol. 26, no. 4, Apr. 2019, pp. 434–42. EBSCOhost, https://doi.org/10.1111/acem.13560.

APA

Beltaief, K., Msolli, M. A., Zorgati, A., Sekma, A., Fakhfakh, M., Marzouk, M. B., Boubaker, H., Grissa, M. H., Methamem, M., Boukef, R., Belguith, A., Bouida, W., Nouira, S., & Heard, K. J. (2019). Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double‐blind Controlled Trial. Academic Emergency Medicine, 26(4), 434–442. https://doi.org/10.1111/acem.13560

Chicago

Beltaief, Kaouthar, Mohamed Amine Msolli, Asma Zorgati, Adel Sekma, Marwen Fakhfakh, Maryem Ben Marzouk, Hamdi Boubaker, et al. 2019. “Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double‐blind Controlled Trial.” Academic Emergency Medicine 26 (4): 434–42. doi:10.1111/acem.13560.